Stock Price Quote

PAR DRUGS AND CHEMICALS LTD.

NSE : PARBSE : ISIN CODE : INE04LG01015Industry : ChemicalsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE215.455.05 (+2.4 %)
PREV CLOSE( ) 210.40
OPEN PRICE ( ) 212.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 215.45 (4000)
VOLUME 26743
TODAY'S LOW / HIGH( ) 211.05 216.00
52 WK LOW / HIGH ( )128.35 248
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-02 1999
Management Info
Falgun Vallabhbhai Savani - Chairman Falgun Vallabhbhai Savani - Managing Director
Registered Office

Address 815, Nilamber Triumph,Gotri Vasna Road, ,
Vadodara,
Gujarat-390007

Phone 0265 2991021 / 2991022

Email admin@pardrugs.com

Website www.pardrugs.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : NSE

NEWS

08Feb Clarification
Par Drugs And Chemicals Limited has informed the Exchange regarding Meet..
08Jan General Announcement
Par Drugs And Chemicals Limited has informed the Exchange about Certific..
28Dec Updates
Par Drugs And Chemicals Limited has informed the Exchange regarding 'Dis..
27Dec Updates
Par Drugs And Chemicals Limited has informed the Exchange regarding 'Upd..
27Dec Closure of Trading Window
Par Drugs And Chemicals Limited has informed the Exchange regarding the..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit34.21113.35
Gross Profit 45.72 150.8
Operating Profit 54.57184.46
Net Sales 239.99957.49

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Polson (BSE)
peergroup  12645.60 (2.05%)
M.Cap ( in Cr)151.75
GOCL Corporation (BSE)
peergroup  453.35 (20.00%)
M.Cap ( in Cr)2247.37
Polychem (BSE)
peergroup  2416.15 (1.66%)
M.Cap ( in Cr)97.62
SRF (BSE)
peergroup  2557.55 (1.38%)
M.Cap ( in Cr)75812.13
Sree Rayal.Hi-Strent (BSE)
peergroup  491.90 (5.55%)
M.Cap ( in Cr)844.34

Shareholding Pattern

PROMOTERS 74.21%
NON-INSTITUTION 25.73%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Par Drugs And Chemicals Ltd.

Par Drugs And Chemicals Ltd. was incorporated in the year 1999. Its today's share price is 0. Its current market capitalisation stands at Rs 265.1 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1083.18 Cr and Total Income of Rs.959.87 Cr. The company's management includes Bintal Bhaveshkumar Shah, Nayna Jignesh Savani, Sanket Bhupendrabhai Trivedi, Krishna Mitulbhai Shah, Kajal Chintanbhai Vaghani, Pravin Manjibhai Bhayani, Ghanshayambhai Bhagvanbhai Savani, Jignesh Vallabhbhai Savani, Falgun Vallabhbhai Savani, Falgun Vallabhbhai Savani.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of PAR and ISIN of INE04LG01015. It's Registered office is at 815, Nilamber Triumph,Gotri Vasna Road, Vadodara-390007, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are DCP & Associates, Sarupria Somani & Associates, V Dhamsania & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.